BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29141994)

  • 1. Type II Diabetes and Incidence of Estrogen Receptor Negative Breast Cancer in African American Women.
    Palmer JR; Castro-Webb N; Bertrand K; Bethea TN; Denis GV
    Cancer Res; 2017 Nov; 77(22):6462-6469. PubMed ID: 29141994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women.
    Barber LE; Zirpoli GR; Cozier YC; Rosenberg L; Petrick JL; Bertrand KA; Palmer JR
    Breast Cancer Res; 2021 Nov; 23(1):108. PubMed ID: 34809694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women?
    Warner ET; Tamimi RM; Boggs DA; Rosner B; Rosenberg L; Colditz GA; Palmer JR
    Cancer Causes Control; 2013 Apr; 24(4):731-9. PubMed ID: 23380944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Patterns of Risk Factors for Early-Onset Breast Cancer by ER Status in African American Women.
    Bertrand KA; Bethea TN; Adams-Campbell LL; Rosenberg L; Palmer JR
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):270-277. PubMed ID: 27756774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin use and risk of breast cancer in African American women.
    Bertrand KA; Bethea TN; Gerlovin H; Coogan PF; Barber L; Rosenberg L; Palmer JR
    Breast Cancer Res; 2020 Sep; 22(1):96. PubMed ID: 32887656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.
    Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI
    J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and breast cancer mortality in Black women.
    Charlot M; Castro-Webb N; Bethea TN; Bertrand K; Boggs DA; Denis GV; Adams-Campbell LL; Rosenberg L; Palmer JR
    Cancer Causes Control; 2017 Jan; 28(1):61-67. PubMed ID: 27995352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pubertal growth and adult height in relation to breast cancer risk in African American women.
    Bertrand KA; Gerlovin H; Bethea TN; Palmer JR
    Int J Cancer; 2017 Dec; 141(12):2462-2470. PubMed ID: 28845597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and perinatal factors and incidence of breast cancer in the Black Women's Health Study.
    Barber LE; Bertrand KA; Rosenberg L; Battaglia TA; Palmer JR
    Cancer Causes Control; 2019 Jan; 30(1):87-95. PubMed ID: 30498869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parity and lactation in relation to estrogen receptor negative breast cancer in African American women.
    Palmer JR; Boggs DA; Wise LA; Ambrosone CB; Adams-Campbell LL; Rosenberg L
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1883-91. PubMed ID: 21846820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.
    Bertrand KA; Bethea TN; Rosenberg L; Bandera EV; Khoury T; Troester MA; Ambrosone CB; Palmer JR
    Breast; 2020 Feb; 49():108-114. PubMed ID: 31786415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
    Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
    Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnicity and breast cancer: factors influencing differences in incidence and outcome.
    Chlebowski RT; Chen Z; Anderson GL; Rohan T; Aragaki A; Lane D; Dolan NC; Paskett ED; McTiernan A; Hubbell FA; Adams-Campbell LL; Prentice R
    J Natl Cancer Inst; 2005 Mar; 97(6):439-48. PubMed ID: 15770008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study.
    Ambrosone CB; Zirpoli G; Ruszczyk M; Shankar J; Hong CC; McIlwain D; Roberts M; Yao S; McCann SE; Ciupak G; Hwang H; Khoury T; Jandorf L; Bovbjerg DH; Pawlish K; Bandera EV
    Cancer Causes Control; 2014 Feb; 25(2):259-65. PubMed ID: 24249438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women.
    Rosenberg L; Bethea TN; Viscidi E; Hong CC; Troester MA; Bandera EV; Haiman CA; Kolonel LN; Olshan AF; Ambrosone CB; Palmer JR
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26613937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.
    Palmer JR; Viscidi E; Troester MA; Hong CC; Schedin P; Bethea TN; Bandera EV; Borges V; McKinnon C; Haiman CA; Lunetta K; Kolonel LN; Rosenberg L; Olshan AF; Ambrosone CB
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25224496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and other anti-diabetic medication use and breast cancer incidence in the Nurses' Health Studies.
    Wang T; Chai B; Chen WY; Holmes MD; Erdrich J; Hu FB; Rosner BA; Tamimi RM; Willett WC; Kang JH; Eliassen AH
    Int J Cancer; 2024 Jul; 155(2):211-225. PubMed ID: 38520039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium.
    Chollet-Hinton L; Olshan AF; Nichols HB; Anders CK; Lund JL; Allott EH; Bethea TN; Hong CC; Cohen SM; Khoury T; Zirpoli GR; Borges VF; Rosenberg LA; Bandera EV; Ambrosone CB; Palmer JR; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1722-1729. PubMed ID: 28903991
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.
    Kerlikowske K; Gard CC; Tice JA; Ziv E; Cummings SR; Miglioretti DL;
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.